KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/12/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization397,521 mln
Float26.87 mln
EPS
114
Stretched
P / E
96.14
Speculative
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-1.48
Manipulation likely
Relative Strength
26
/ 100
Underperforming
Debt / Equity
0.13
Very low leverage
Business Description
Founded in 1998 and headquartered in Namyangju-si, South Korea, HLB Pharmaceutical Co. Ltd. is a drug research and development company formerly known as Mediforum Pharmaceutical Incorporation. The company produces a broad range of medicines spanning areas such as pain relief, digestive health, skin care, cardiovascular support, and central nervous system treatment, among many others. HLB Pharmaceutical is also advancing CTT-004, an investigational treatment for a movement disorder caused by spinocerebellar degeneration, and provides contract manufacturing services to outside clients.
